Pharmaceutical Waste Gas Emission Testing: Standards, Parameters, and Analytical Methods

Pharmaceutical waste gas emission testing is the systematic sampling and analysis of exhaust streams from drug manufacturing facilities to verify compliance with national limits for volatile organic compounds (VOCs), acid gases, particulate matter, and odorants under standards such as GB 37823-2019. This technical guide explains the applicable emission standards, sampling points, testing parameters, and analytical methods used by accredited third-party laboratories to support environmental compliance in the pharmaceutical industry.

Technical Overview

Pharmaceutical waste gas emission testing is the systematic sampling and chemical analysis of exhaust streams generated by drug manufacturing processes, including active pharmaceutical ingredient (API) synthesis, fermentation, extraction, formulation, drying, and solvent recovery. These exhaust streams typically contain volatile organic compounds (VOCs) such as methanol, acetone, dichloromethane, toluene, ethyl acetate, and acetonitrile, together with acid gases, ammonia, particulate matter, and malodorous substances. Because many of these pollutants are toxic, flammable, or photochemically reactive, national and regional regulations impose strict emission limits that facilities must verify through periodic stack testing.

In the Chinese regulatory framework, the sector-specific standard GB 37823-2019 (Emission Standard of Air Pollutants for the Pharmaceutical Industry) establishes concentration limits for non-methane hydrocarbons (NMHC), particulate matter, and related parameters, together with minimum removal efficiency requirements for waste gas treatment systems. Pollutants not covered by the sectoral standard fall under the integrated standard GB 16297-1996, odor emissions are regulated by GB 14554-1993, and fugitive (unorganized) VOC emissions are controlled under GB 37822-2019. Incineration units used for solvent or hazardous waste streams must additionally meet GB 18484, including limits for dioxins and furans.

Reported results are converted to standard conditions (273.15 K, 101.325 kPa, dry basis) and expressed as mass concentration (mg/m³) or mass emission rate (kg/h). For exhaust discharged from combustion-type treatment equipment, concentrations are corrected to a specified reference oxygen content where the applicable standard requires it. Testing is normally performed by accredited third-party laboratories using validated sampling and analytical methods, under production conditions representative of normal plant operation.

Testing Samples

Organized Emissions from Process Exhaust Stacks

Samples are collected at permanent sampling ports located on stacks and vents serving API synthesis workshops, solvent recovery towers, crystallization and drying units, tablet coating and granulation lines, fermentation off-gas systems, and dust collection networks. Particulate-bound pollutants are sampled isokinetically, while gaseous pollutants are captured by direct sampling, absorption in impingers, inert sampling bags, or adsorption tubes depending on the target analyte.

Inlet and Outlet Streams of Waste Gas Treatment Facilities

Paired samples are taken simultaneously before and after treatment equipment such as regenerative thermal oxidizers (RTO), activated carbon adsorbers, scrubbers, and bag filters. Comparing inlet and outlet mass emission rates allows direct verification of the removal efficiency required by the discharge permit and by GB 37823-2019.

Fugitive Emissions at Plant and Workshop Boundaries

Ambient air samples are collected at upwind and downwind boundary points in accordance with GB 37822-2019 and GB 16297-1996 to assess unorganized emissions from storage tanks, material transfer operations, open process equipment, and building ventilation. Component-level leak screening of pumps, valves, and flanges may also be performed as part of a leak detection and repair (LDAR) program.

Specialized Exhaust Streams

Dedicated sampling programs address incinerator flue gas (dioxins, furans, mercury, and heavy metals), odor collection systems serving wastewater treatment plants, and tank breathing and loading losses, each of which requires project-specific sampling arrangements and holding-time controls.

Testing Items

The testing program is built around the pollutant categories regulated for pharmaceutical manufacturing:

• Total hydrocarbons and non-methane hydrocarbons (THC and NMHC) as the primary VOC compliance indicators
• Speciated VOCs and solvents, including methanol, ethanol, acetone, isopropanol, ethyl acetate, dichloromethane, chloroform, trichloroethylene, toluene, xylene, benzene, acetonitrile, tetrahydrofuran, dimethylformamide, and formaldehyde
• Acid gases, including hydrogen chloride, hydrogen fluoride, chlorine, and sulfuric acid mist
• Alkaline and odorous gases, including ammonia, hydrogen sulfide, methyl mercaptan, trimethylamine, and odor concentration (dimensionless)
• Combustion-related gases, including sulfur dioxide, nitrogen oxides, and carbon monoxide
• Particulate matter and dust from granulation, milling, and coating operations
• Dioxins and furans (PCDD/Fs) and mercury compounds where incineration or specific raw materials are involved

In parallel with pollutant concentrations, flue gas parameters are measured at every sampling point, including temperature, flow velocity, volumetric flow rate, moisture content, and oxygen content, which are required for mass emission rate calculation and excess air correction.

Testing Methods

Sampling follows the fundamental procedures of GB/T 16157-1996 and, for particulate matter, the isokinetic gravimetric approach aligned with ISO 9096. Gas velocity is determined with S-type pitot tubes, and at least three valid sampling cycles are completed at each point under stable production load. VOC samples are captured in inert bags or adsorption tubes, inorganic gases are absorbed in suitable impinger solutions, and samples are transported under controlled conditions within defined holding times.

• NMHC and total hydrocarbons: gas chromatography with flame ionization detection (GC-FID) per HJ 38
• Speciated VOCs: bag or adsorption-tube sampling with gas chromatography-mass spectrometry (GC-MS) per HJ 732 and HJ 734
• Particulate matter: isokinetic sampling with gravimetric determination per GB/T 16157 and ISO 9096
• Sulfur dioxide: electrochemical, non-dispersive infrared, or ultraviolet fluorescence instrumental methods per HJ 57
• Nitrogen oxides: electrochemical, chemiluminescence, or non-dispersive infrared methods per HJ 693
• Carbon monoxide: non-dispersive infrared absorption
• Hydrogen chloride and hydrogen fluoride: impinger absorption followed by ion chromatography or silver nitrate titration
• Ammonia: Nessler or indophenol blue spectrophotometry
• Hydrogen sulfide: methylene blue spectrophotometry
• Odor concentration: triangle odor bag method per GB/T 14675 or dynamic olfactometry per EN 13725
• Dioxins and furans: isotope dilution high-resolution GC-MS per HJ 77.2
• Multi-component screening: extractive Fourier transform infrared spectroscopy per ASTM D6348

Quality assurance measures include calibration gases traceable to national metrology institutes, field blanks, parallel duplicate samples, sampling train leak checks, and documented operating conditions during each run. Major emission sources may additionally require continuous emission monitoring systems (CEMS) for NMHC and combustion gases, installed and validated in accordance with the HJ 75, HJ 76, and HJ 1013 technical specifications.

Applications

Pharmaceutical waste gas emission testing supports compliance and process decision-making across the full life cycle of a manufacturing site:

• Periodic compliance self-monitoring required under pollutant discharge permits
• Completion acceptance monitoring for new plants, expansion projects, and upgraded treatment systems
• Commissioning and performance verification of RTO, adsorption, scrubbing, and dust filtration equipment
• Verification of environmental impact assessment predictions and clean production audits
• Investigation of odor complaints and root-cause diagnosis of exceedances
• Leak detection and repair programs for fugitive VOC control at component and boundary level
• Environmental due diligence and ESG reporting for site transactions and corporate disclosure

FAQ

Which emission standards apply to pharmaceutical manufacturing plants?

GB 37823-2019 is the sector-specific standard for the pharmaceutical industry and takes priority where it specifies limits. Pollutants not covered by it are governed by the integrated standard GB 16297-1996, odor pollutants by GB 14554-1993, and fugitive VOC emissions by GB 37822-2019. Incineration units must meet GB 18484, and where stricter local or regional standards exist, the stricter requirement applies.

Why is NMHC the key compliance indicator for VOC control?

Non-methane hydrocarbons represent the aggregate concentration of all hydrocarbon species excluding methane and serve as a practical surrogate for overall solvent emission control. NMHC is measured by GC-FID, reported in mg/m³ at standard conditions, and is the parameter on which most pharmaceutical stack limits and treatment efficiency requirements in GB 37823-2019 are based.

How often must waste gas emissions be tested?

Monitoring frequency is defined in each facility's pollutant discharge permit and typically ranges from monthly to semi-annually depending on the classification of the emission source. Sources designated as major emitters are generally required to install and operate CEMS for continuous monitoring, supplemented by periodic manual testing for method validation and compliance confirmation.

How is the removal efficiency of treatment equipment verified?

Inlet and outlet streams are sampled simultaneously while the production line and treatment system operate at stable, representative load. Removal efficiency is calculated from the ratio of outlet to inlet mass emission rates, and at least three valid paired sampling cycles are required to demonstrate that the minimum efficiency specified in the standard and permit has been achieved.

What is the difference between organized and fugitive emission testing?

Organized emission testing is conducted at defined stack sampling ports and yields pollutant concentrations and mass emission rates for a specific discharge point. Fugitive emission testing measures ambient concentrations at plant and workshop boundaries or at individual equipment components to quantify uncontrolled releases from storage, transfer, and process operations that do not pass through a stack.

Can emission testing be performed during commissioning or maintenance periods?

Compliance testing must reflect normal operating conditions, so sampling during start-up, shutdown, or maintenance is generally not acceptable for permit verification. However, commissioning-stage testing is valuable for tuning RTO operating temperatures, verifying adsorption breakthrough behavior, and establishing baseline data before formal acceptance monitoring is conducted.